Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in adults with ADHD
NCT00940693Phase 2Completed
- Sponsor
- Université de Montréal
- Start
- Aug 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of duloxetine in attention deficit hyperactivity disorder (ADHD), sponsored by Université de Montréal. Started Aug 2009; status: completed.
02
Drugs
duloxetine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00940693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00940693.